NCT03542682View on ClinicalTrials.gov

The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

September 23, 2022

Study Completion Date

September 23, 2022

Conditions
Type1diabetes
Interventions
DEVICE

Quick Bolus

"Individuals with Type 1 Diabetes (T1D) given 0.2 units/kg of rapid acting insulin (RAI) via quick bolus of 15 units per minute during a euglycemic clamp."

DEVICE

Standard Bolus

"Individuals with Type 1 Diabetes (T1D) given 0.2 units/kg of rapid acting insulin (RAI) via standard bolus of 1.5 units per minute during a euglycemic clamp."

Trial Locations (1)

06520

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03542682 - The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes | Biotech Hunter | Biotech Hunter